- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- August 2024
- 249 Pages
Global, Europe, United States, ... Global, Europe, United States, Japan
From €2340EUR$2,450USD£1,957GBP
- Report
- October 2024
- 182 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 89 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- March 2025
- 200 Pages
Global
From €2378EUR$2,490USD£1,989GBP
- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- May 2024
- 184 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- July 2024
- 150 Pages
Global
From €3581EUR$3,750USD£2,995GBP
- Report
- December 2022
- 223 Pages
Global
From €2507EUR$2,625USD£2,096GBP
€5014EUR$5,250USD£4,193GBP
- Report
- August 2024
- 120 Pages
India
From €2321EUR$2,430USD£1,941GBP
€2579EUR$2,700USD£2,156GBP
- Report
- December 2023
- 152 Pages
Global
From €5682EUR$5,950USD£4,752GBP
- Report
- December 2024
- 82 Pages
India
From €3343EUR$3,500USD£2,795GBP
- Report
- September 2024
- 88 Pages
Egypt
From €3343EUR$3,500USD£2,795GBP
- Report
- July 2024
- 82 Pages
India
From €3343EUR$3,500USD£2,795GBP
- Report
- February 2024
- 117 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- April 2023
- 124 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- November 2021
- 119 Pages
Global
From €4298EUR$4,500USD£3,594GBP
€4536EUR$4,750USD£3,794GBP
- Report
- October 2023
- 104 Pages
Global
From €3500EUR$3,926USD£3,029GBP
- Report
- June 2023
- 94 Pages
Global
From €3500EUR$3,926USD£3,029GBP

The Prostate Specific Antigen (PSA) Test is a diagnostic tool used to detect the presence of prostate cancer in men. It measures the amount of PSA, a protein produced by the prostate gland, in the blood. Elevated levels of PSA may indicate the presence of prostate cancer, although other conditions such as benign prostatic hyperplasia can also cause elevated PSA levels. The PSA Test is typically used in conjunction with other tests such as digital rectal examination and biopsy to confirm a diagnosis of prostate cancer.
The PSA Test market is a subset of the larger Diagnostics market, which includes a wide range of tests used to diagnose and monitor diseases. The Diagnostics market is highly competitive, with a variety of companies offering a range of products and services.
Some companies in the Prostate Specific Antigen Test market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Quest Diagnostics. Show Less Read more